By Brian M. Reiser Ocugen Inc (Nasdaq: OCGN) recently saw a staggering gain of over 800% over the trading period between December 21st through 23rd, thanks to news of its co-development of a COVID-19 vaccine. But is this rally for real? And what does it mean for the future of Ocugen stock?
In this article, we’ll take a closer look at the company’s recent binding agreement to develop this vaccine, and we’ll dive into some fundamentals regarding the stock itself.
Ocugen Stock Rallies on Vaccine News
Ocugen stock’s 800% rally occurred on the news that the biopharma company is co-developing a new COVID-19 vaccine. The company signed …read more
